5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma

Y. Maehara, T. Kusumoto, Y. Emi, H. Anai, Y. Sakaguchi, S. Kohnoe, K. Sugimachi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The sensitivity to 5-flourouracil (5-FU) was examined in 40 well differentiated and 50 poorly differentiated gastric cancer tissues and 15 normal tissues, using the in vitro succinate dehydrogenase inhibition (SDI) test. The tissue phosphorylating and degrading activities of 5-FU were compared in each type of tumor and in the normal tissues. Decreases in succinate dehydrogenase (SD) activity were more apparent in the poorly differentiated cancer tissues than in the well differentiated cancer tissues (p < 0.005), and than in the normal tissues (p < 0.001), exposed to 5-FU. The rate of sensitivity to 5-FU was higher in the poorly differentiated than in the well differentiated tissues and than in the normal tissues. The phosphorylating activities of 5-FU, in pathways involving uridine (Urd) phosphorylase and Urd Kinase, and thymidine (dThd) phosphorylase and dThd Kinase, were 1.7 fold higher in the poorly differentiated than in the well differentiated tissues and several fold higher than in the normal tissues (p < 0.05-p < 0.001). The degrading activity of 5-FU was similar in both types of tumor and in the normal tissues. Our findings show that 5-FU is actively metabolized to 5-FU-nucleotides in poorly differentiated tissues after incorporation into the tumor cells. 5-FU seems to have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

Original languageEnglish
Pages (from-to)1091-1094
Number of pages4
JournalAnticancer research
Volume10
Issue number4
Publication statusPublished - Jan 1 1990

Fingerprint

Fluorouracil
Stomach
Nucleotides
Carcinoma
Phosphorylase Kinase
Succinate Dehydrogenase
Neoplasms
Uridine Phosphorylase
Uridine Kinase
Thymidine Phosphorylase
Stomach Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma. / Maehara, Y.; Kusumoto, T.; Emi, Y.; Anai, H.; Sakaguchi, Y.; Kohnoe, S.; Sugimachi, K.

In: Anticancer research, Vol. 10, No. 4, 01.01.1990, p. 1091-1094.

Research output: Contribution to journalArticle

Maehara, Y, Kusumoto, T, Emi, Y, Anai, H, Sakaguchi, Y, Kohnoe, S & Sugimachi, K 1990, '5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma', Anticancer research, vol. 10, no. 4, pp. 1091-1094.
Maehara, Y. ; Kusumoto, T. ; Emi, Y. ; Anai, H. ; Sakaguchi, Y. ; Kohnoe, S. ; Sugimachi, K. / 5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma. In: Anticancer research. 1990 ; Vol. 10, No. 4. pp. 1091-1094.
@article{fe61970792d048b594cc0353503c62f7,
title = "5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma",
abstract = "The sensitivity to 5-flourouracil (5-FU) was examined in 40 well differentiated and 50 poorly differentiated gastric cancer tissues and 15 normal tissues, using the in vitro succinate dehydrogenase inhibition (SDI) test. The tissue phosphorylating and degrading activities of 5-FU were compared in each type of tumor and in the normal tissues. Decreases in succinate dehydrogenase (SD) activity were more apparent in the poorly differentiated cancer tissues than in the well differentiated cancer tissues (p < 0.005), and than in the normal tissues (p < 0.001), exposed to 5-FU. The rate of sensitivity to 5-FU was higher in the poorly differentiated than in the well differentiated tissues and than in the normal tissues. The phosphorylating activities of 5-FU, in pathways involving uridine (Urd) phosphorylase and Urd Kinase, and thymidine (dThd) phosphorylase and dThd Kinase, were 1.7 fold higher in the poorly differentiated than in the well differentiated tissues and several fold higher than in the normal tissues (p < 0.05-p < 0.001). The degrading activity of 5-FU was similar in both types of tumor and in the normal tissues. Our findings show that 5-FU is actively metabolized to 5-FU-nucleotides in poorly differentiated tissues after incorporation into the tumor cells. 5-FU seems to have an increased susceptibility in cases of poorly differentiated gastric carcinoma.",
author = "Y. Maehara and T. Kusumoto and Y. Emi and H. Anai and Y. Sakaguchi and S. Kohnoe and K. Sugimachi",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "10",
pages = "1091--1094",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - 5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma

AU - Maehara, Y.

AU - Kusumoto, T.

AU - Emi, Y.

AU - Anai, H.

AU - Sakaguchi, Y.

AU - Kohnoe, S.

AU - Sugimachi, K.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The sensitivity to 5-flourouracil (5-FU) was examined in 40 well differentiated and 50 poorly differentiated gastric cancer tissues and 15 normal tissues, using the in vitro succinate dehydrogenase inhibition (SDI) test. The tissue phosphorylating and degrading activities of 5-FU were compared in each type of tumor and in the normal tissues. Decreases in succinate dehydrogenase (SD) activity were more apparent in the poorly differentiated cancer tissues than in the well differentiated cancer tissues (p < 0.005), and than in the normal tissues (p < 0.001), exposed to 5-FU. The rate of sensitivity to 5-FU was higher in the poorly differentiated than in the well differentiated tissues and than in the normal tissues. The phosphorylating activities of 5-FU, in pathways involving uridine (Urd) phosphorylase and Urd Kinase, and thymidine (dThd) phosphorylase and dThd Kinase, were 1.7 fold higher in the poorly differentiated than in the well differentiated tissues and several fold higher than in the normal tissues (p < 0.05-p < 0.001). The degrading activity of 5-FU was similar in both types of tumor and in the normal tissues. Our findings show that 5-FU is actively metabolized to 5-FU-nucleotides in poorly differentiated tissues after incorporation into the tumor cells. 5-FU seems to have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

AB - The sensitivity to 5-flourouracil (5-FU) was examined in 40 well differentiated and 50 poorly differentiated gastric cancer tissues and 15 normal tissues, using the in vitro succinate dehydrogenase inhibition (SDI) test. The tissue phosphorylating and degrading activities of 5-FU were compared in each type of tumor and in the normal tissues. Decreases in succinate dehydrogenase (SD) activity were more apparent in the poorly differentiated cancer tissues than in the well differentiated cancer tissues (p < 0.005), and than in the normal tissues (p < 0.001), exposed to 5-FU. The rate of sensitivity to 5-FU was higher in the poorly differentiated than in the well differentiated tissues and than in the normal tissues. The phosphorylating activities of 5-FU, in pathways involving uridine (Urd) phosphorylase and Urd Kinase, and thymidine (dThd) phosphorylase and dThd Kinase, were 1.7 fold higher in the poorly differentiated than in the well differentiated tissues and several fold higher than in the normal tissues (p < 0.05-p < 0.001). The degrading activity of 5-FU was similar in both types of tumor and in the normal tissues. Our findings show that 5-FU is actively metabolized to 5-FU-nucleotides in poorly differentiated tissues after incorporation into the tumor cells. 5-FU seems to have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0025345984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025345984&partnerID=8YFLogxK

M3 - Article

C2 - 2382981

AN - SCOPUS:0025345984

VL - 10

SP - 1091

EP - 1094

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -